SECTOR:
Oncology
FUND/VEHICLE:
NFLS Direct Investment
INVESTMENT DATE:
2018
GEOGRAPHY:
North America
STATUS CURRENT/FORMER INVESTMENT:
Existing
WEBSITE:
FogPharma is pioneering cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them.